Venous Thromboembolism
Venous Thromboembolism (VTE) is a disorder that includes deep vein thrombosis (DVT), where a blood clot forms in a deep vein (usually in the leg), and pulmonary embolism (PE), where a clot breaks free and travels to lodge in the lungs. This condition encompasses DVT only, PE only, or a combination of both.
Health Outcomes
- Delayed Onset of Phlebitis Symptom
- Enhanced Aggregation Abilities
- Enhanced Co-aggregation Ability
- Improved Aggregation Ability
- Improved Anticoagulatory Effects
- Improved Antithrombotic Prevention
- Improved Blood Coagulation
- Improved Coagulation Parameters
- Improved Fibrinolytic Activity
- Improved INR Control
- Improved Thrombolytic Property
- Incidence of Thrombosis
- Increased Blood Homocysteine Level
- Increased Cell Adhesion
- Increased Leg Circumference
- Increased Nattokinase Activity
- Increased Plasminogen Activator Inhibitor-1 Level
- Inhibited Platelet Aggregation
- Modulated Retrograde Blood Flow
- Prolonged Survival Periods with Antiphospholipid Syndrome
- Reduced Blood Fibrinogen Concentrations
- Reduced Extremity Swelling
- Reduced INR
- Reduced Incidence of Total Adverse Effects
- Reduced Phlebitis Incidence
- Reduced Phlebitis Severity
- Reduced Platelet Aggregation
- Reduced Thrombosis
- Reduced Thrombotic Risk
- Reduced Thromboxane A2 Level
- Reduced Vascular Permeability